Evidence map›Paper›PMID 42520119›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

An antibody-drug conjugate active against antibiotic-resistant

Hayley Lavender, Vincent Oliver, Daniel Lucy, Timothy A Barendt, Ann E Jerse, Christoph M Tang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hayley LavenderSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.ORCID 0000-0001-9996-8107
Vincent OliverHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817.ORCID 0009-0008-3862-9716
Daniel LucyDepartment of Chemistry, University of Oxford, Oxford OX1 3TA, United Kingdom.
Timothy A BarendtDepartment of Chemistry, University of Oxford, Oxford OX1 3TA, United Kingdom.
Ann E JerseDepartment of Microbiology and Immunology, Uniformed Services, University of the Health Sciences, Bethesda, MD 20814.ORCID 0000-0002-5118-3172
Christoph M TangSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.ORCID 0000-0001-8366-3245

Funding

¿¿¿¿ | John Fell Fund, University of Oxford (John Fell OUP Research Fund) HL 2024Rosetrees Trust (Rosetrees) Seedcorn2023 \ 100188Wellcome TrustWellcome Trust (WT) 214374/Z/18/ZWellcome Trust (WT) 221924/Z/20/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesDrug Resistance, BacterialImmunoconjugatesNeisseria gonorrhoeaeAntibodies, MonoclonalBacterial Outer Membrane ProteinsBacterial ProteinsGonorrheaHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAntibodies, MonoclonalAntimicrobial PeptidesBacterial Outer Membrane ProteinsBacterial ProteinsImmunoconjugatesMtrE protein, Neisseria gonorrhoeaeantibody–drug conjugateantimicrobial peptideantimicrobial resistanceIgA proteaseNeisseria gonorrhoeae

Identifiers

PMID42520119
PMCPMC13439108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.